Ask The Doctors: 08/07

This is a challenging question and the source of much media attention and controversy. The differentiation between "on-label" and "off-label" has do to with whether the U.S. Food and Drug Administration (FDA) determines that there is enough evidence of benefit and safety supporting a specific use of the product that this information should be on the package insert that comes with the drug or device. "Off label" uses for a stent could include treating bypass graft lesions or for lesions of a certain size not specified on the label. In general, "on-label" products have more data to support their use for those purposes.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access